SlideShare a Scribd company logo
1 of 6
Download to read offline
To The
President
MCI
Dear Madam
This is about the following circular being issued by the MCI.
However, the clause 1.5 of the Indian Medical Council (Professional Conduct, Etiquette and
Ethics) Regulations, 2002 has been amended in 2016 and notified in the Gazette of India on
21.09.2016, which reads as under:
"1.5 - Use of Generic names of drugs: Every physician should prescribe drugs with generic
names legibly and preferably in capital letters and he/ she shall ensure that there is a rational
prescription and use of drugs."
IMA Observation:
1. Use of Generic names of drugs: Means the chemical name of the drug
2. Every physician: Means all doctors registered under IMR
3. ‘should” means discretional and non-mandatory
4. prescribe drugs with generic names: Means writing chemical name of the drug
5. Legibly: Means readable (does not mandate electronic writing)
6. and preferably (where ever possible and is non-mandatory)
7. in capital letters (pertains to the chemical name)
8. and he/ she shall ensure that there is a rational prescription and use of drugs means this
part of the clause is mandatory (shall)
B: All the Registered Medical Practitioners under the IMC Act are directed to comply with
the aforesaid provisions of the Regulations without fail.
IMA observation: To follow the above in its letter and spirit
C: You are requested to give wide publicity of the above regulation to ensure that all the
doctors practicing medicine under your jurisdiction comply with the regulation.
IMA observation: IMA needs to disseminate this information.
D: All concerned are once again urged to take necessary steps for observance of the
aforesaid provision of the Indian Medical Council (Professional Conduct, Etiquette and
Ethics) Regulations, 2002 in its letter and spirit.
IMA observation: same as B.
E: For any doctor found violating clause l.5 of Ethics Regulation, suitable disciplinary
action would be undertaken by the concerned SMC/MCI.
IMA Observation: Only the mandatory portion of the clause can be actionable. The prescription
shall have rationality of treatment and the drugs prescribed. The non-mandatory initial part of the
clause can-not lead to action by SMCs as it is discretionary.
F: “should prescribe drugs with generic names”: It does not write "only with generic
names". It does not prohibit a doctor from writing the name of the company or the brand.
For example when writing a generic name, we need to write the word ‘Jan Aushidhi’ in the
prescription otherwise he or she will not get the cheapest quality drug etc.
This classification may kindly be circulated to the SMCs to avoid any misunderstanding in
its interpretation.
Dr KK Aggarwal
National President, IMA
Background Note
Generic drugs prescription
Dr KK Aggarwal
The current law situation is
““Every physician should prescribe drugs with generic names legibly and preferably in capital
letters and he/she shall ensure that there is a rational prescription and use of drugs”
1. Every physician means all of us
2. ‘Should” means may and may means optional or preferable
3. Drugs with generic names means the chemical name of the drug
4. Legibly : means readable
a. It does not mandate electronic prescription
b. It does not mandate or it would have been shall and not should
c. It does not include the word “only’ it only manes naming the chemical name of the drug
In India. chemical generic name of the drug is available in three formats
Generic generic
Generic trade
And generic brand
All companies make all three versions. Generic brands are the costliest with no difference in quality
IMA Stand
1. Choose drugs from national list of essential medicines (They are cheaper and of quality and
efficacy)
2. When writing non NLEM take consent
3. When prescribing, write the cheapest available medicine and that will always be the generic-
generic version of that company
4. Best will be to write the name of the salt and the name of the company you want to choose. No-
body can stop you choosing the company for quality assurance.
5. When writing paracetamol from jan aushidhi you have to write the name jan aushidhi
No. MCI-211(2)(Gen.)/2017-Ethics/104728
Date: 21/04/2017
To,
1. Dean/Principals of all the Medical Colleges, 2. Director of all the hospitals (exclusive
PG Institutions without medical colleges), 3. President, all the State Medical
Councils.
5. Health Secretary of all the States.; 5. The Director of Medical Education, all States
with request to ensure compliance.6. The Director of Health Services, all States with
request to ensure compliance and inform about action taken.
Madam/Sir,
Your kind attention is invited to circular no. MCI-211(2)(Gen.)/2012-Ethics/145183 dated
22.11.2012 & 18.01.2013.
The said circular had called upon the doctors practicing medicine to prescribe Drugs with
Generic name as far as possible.
However, the clause 1.5 of the Indian Medical Council (Professional Conduct, Etiquette
and Ethics) Regulations, 2002 has been amended in 2016 and notified in the Gazette of
India on 21.09.2016, which reads as under:-
"1.5 - Use of Generic names of drugs: Every physician should prescribe drugs with
generic names legibly and preferably in capital letters and he/ she shall ensure that there is
a rational prescription and use of drugs."
All the Registered Medical Practitioners under the IMC Act are directed to comply with the
aforesaid provisions of the Regulations without fail.
You are requested to give wide publicity of the above regulation to ensure that all the
doctors practicing medicine under your jurisdiction comply with the regulation.“
All concerned are once again urged to take necessary steps for observance of the aforesaid
provision of the Indian Medical Council (Professional Conduct, Etiquette and Ethics)
Regulations, 2002 in its letter and spirit.
For any doctor found violating clausel.5 of Ethics Regulation, suitable disciplinary action
would be undertaken by the concerned SMC/MCI.
Secretary MCI
IMA Comments
Should is discretionary
“ All the Registered Medical Practitioners under the IMC Act are directed to comply with
the aforesaid provisions of the Regulations without fail”
“For any doctor found violating clause l.5 of Ethics Regulation, suitable disciplinary action
would be undertaken by the concerned SMC/MCI”
We need to read the circular as a whole and not the first part only which is not mandated.
The one which is mandated is (shall) is the second part of the clause and that is rational
prescription. Only any irrational prescription can lead to an action.
The first part of the clause contains the word ‘should” and not shall. Should is always
discretionary.
No. MCI-211(2)(Gen.)/2017-Ethics/104728
Date: 21/04/2017
To,
2. Dean/Principals of all the Medical Colleges, 2. Director of all the hospitals
(exclusive PG Institutions without medical colleges), 3. President, all the
State Medical Councils.
7. Health Secretary of all the States.; 5. The Director of Medical Education, all States
with request to ensure compliance.6. The Director of Health Services, all States with
request to ensure compliance and inform about action taken.
8.
Madam/Sir,
Your kind attention is invited to circular no. MCI-211(2)(Gen.)/2012-Ethics/145183 dated
22.11.2012 & 18.01.2013.
The said circular had called upon the doctors practicing medicine to prescribe Drugs with
Generic name as far as possible.
However, the clause 1.5 of the Indian Medical Council (Professional Conduct, Etiquette
and Ethics) Regulations, 2002 has been amended in 2016 and notified in the Gazette of
India on 21.09.2016, which reads as under:-
"1.5 - Use of Generic names of drugs: Every physician should prescribe drugs with
generic names legibly and preferably in capital letters and he/ she shall ensure that there is
a rational prescription and use of drugs."
All the Registered Medical Practitioners under the IMC Act are directed to comply with the
aforesaid provisions of the Regulations without fail.
You are requested to give wide publicity of the above regulation to ensure that all the
doctors practicing medicine under your jurisdiction comply with the regulation.“
All concerned are once again urged to take necessary steps for observance of the aforesaid
provision of the Indian Medical Council (Professional Conduct, Etiquette and Ethics)
Regulations, 2002 in its letter and spirit.
For any doctor found violating clausel.5 of Ethics Regulation, suitable disciplinary action
would be undertaken by the concerned SMC/MCI.
Secretary MCI

More Related Content

What's hot

Virechana tirupati 1 dr.santosh bhattded
Virechana tirupati 1  dr.santosh bhattdedVirechana tirupati 1  dr.santosh bhattded
Virechana tirupati 1 dr.santosh bhattdedDr.B.Arun kumar Kumar
 
Pediatric Posology In Ayurvead
Pediatric Posology In AyurveadPediatric Posology In Ayurvead
Pediatric Posology In AyurveadArun Chhajer
 
SHARANGDHARA SAMHITA-Dr.MEENU SWAMINATH
SHARANGDHARA SAMHITA-Dr.MEENU SWAMINATHSHARANGDHARA SAMHITA-Dr.MEENU SWAMINATH
SHARANGDHARA SAMHITA-Dr.MEENU SWAMINATHMeenu Swaminath
 
Concept kala sharir by dr. jeet
Concept kala sharir by dr. jeetConcept kala sharir by dr. jeet
Concept kala sharir by dr. jeetJeetdansana
 
Uttara basti Indications & Contraindications
Uttara basti Indications & ContraindicationsUttara basti Indications & Contraindications
Uttara basti Indications & ContraindicationsAkshay Shetty
 

What's hot (6)

Virechana tirupati 1 dr.santosh bhattded
Virechana tirupati 1  dr.santosh bhattdedVirechana tirupati 1  dr.santosh bhattded
Virechana tirupati 1 dr.santosh bhattded
 
Pediatric Posology In Ayurvead
Pediatric Posology In AyurveadPediatric Posology In Ayurvead
Pediatric Posology In Ayurvead
 
SHARANGDHARA SAMHITA-Dr.MEENU SWAMINATH
SHARANGDHARA SAMHITA-Dr.MEENU SWAMINATHSHARANGDHARA SAMHITA-Dr.MEENU SWAMINATH
SHARANGDHARA SAMHITA-Dr.MEENU SWAMINATH
 
Concept kala sharir by dr. jeet
Concept kala sharir by dr. jeetConcept kala sharir by dr. jeet
Concept kala sharir by dr. jeet
 
samanya vishesh.pdf
samanya vishesh.pdfsamanya vishesh.pdf
samanya vishesh.pdf
 
Uttara basti Indications & Contraindications
Uttara basti Indications & ContraindicationsUttara basti Indications & Contraindications
Uttara basti Indications & Contraindications
 

Similar to IMA Letter on Prescribing Generics

Clinician view point on prescribing Generic Medicine
Clinician view  point on prescribing Generic MedicineClinician view  point on prescribing Generic Medicine
Clinician view point on prescribing Generic MedicineDr.Vinod Sharma
 
IntroductiontoPharmacyPharmaceutics.pptx
IntroductiontoPharmacyPharmaceutics.pptxIntroductiontoPharmacyPharmaceutics.pptx
IntroductiontoPharmacyPharmaceutics.pptxPrachi Pandey
 
Introduction to Pharmacy & Pharmaceutics.pptx
Introduction to Pharmacy & Pharmaceutics.pptxIntroduction to Pharmacy & Pharmaceutics.pptx
Introduction to Pharmacy & Pharmaceutics.pptxRAHUL PAL
 
Fixed dose combination products – rationality, status in india, development i...
Fixed dose combination products – rationality, status in india, development i...Fixed dose combination products – rationality, status in india, development i...
Fixed dose combination products – rationality, status in india, development i...Dr Sukanta sen
 
The obnoxious practice of drug companies
The obnoxious practice of drug companiesThe obnoxious practice of drug companies
The obnoxious practice of drug companiesDr Aneek Gupta
 
FDC Ban - What's Right and What's Wrong?
FDC Ban - What's Right and What's Wrong?FDC Ban - What's Right and What's Wrong?
FDC Ban - What's Right and What's Wrong?Anup Soans
 
Pharma Malpractices - Report of the Parliament Committee to Rajya Sabha
Pharma Malpractices - Report of the Parliament Committee to Rajya Sabha Pharma Malpractices - Report of the Parliament Committee to Rajya Sabha
Pharma Malpractices - Report of the Parliament Committee to Rajya Sabha Anup Soans
 
Regulatory issues regulations in india asu
Regulatory issues   regulations in india asuRegulatory issues   regulations in india asu
Regulatory issues regulations in india asuMohammad Khalid
 
History of pharmacy and pharmacopoeia
History of pharmacy and pharmacopoeiaHistory of pharmacy and pharmacopoeia
History of pharmacy and pharmacopoeiajagan vana
 
India Ayurvedic.pdf Ayurveda Samhitha ayurvedic
India Ayurvedic.pdf Ayurveda Samhitha ayurvedicIndia Ayurvedic.pdf Ayurveda Samhitha ayurvedic
India Ayurvedic.pdf Ayurveda Samhitha ayurvedicKrishMotupalli
 
Sources of drug information
Sources of drug informationSources of drug information
Sources of drug informationArvind Kumar
 
Pharmacy and Therapeutic committee
Pharmacy and Therapeutic committeePharmacy and Therapeutic committee
Pharmacy and Therapeutic committeeAPOLLO JAMES
 
Pharmacy history, pharmacopoeia
Pharmacy history, pharmacopoeiaPharmacy history, pharmacopoeia
Pharmacy history, pharmacopoeiaArshad Khan
 
Write a rational, correct and legible generic prescription for a given condit...
Write a rational, correct and legible generic prescription for a given condit...Write a rational, correct and legible generic prescription for a given condit...
Write a rational, correct and legible generic prescription for a given condit...Dr Pankaj Kumar Gupta
 

Similar to IMA Letter on Prescribing Generics (20)

Clinician view point on prescribing Generic Medicine
Clinician view  point on prescribing Generic MedicineClinician view  point on prescribing Generic Medicine
Clinician view point on prescribing Generic Medicine
 
Can a mbbs doctor do surgery by n
Can a mbbs doctor do surgery by nCan a mbbs doctor do surgery by n
Can a mbbs doctor do surgery by n
 
IntroductiontoPharmacyPharmaceutics.pptx
IntroductiontoPharmacyPharmaceutics.pptxIntroductiontoPharmacyPharmaceutics.pptx
IntroductiontoPharmacyPharmaceutics.pptx
 
Introduction to Pharmacy & Pharmaceutics.pptx
Introduction to Pharmacy & Pharmaceutics.pptxIntroduction to Pharmacy & Pharmaceutics.pptx
Introduction to Pharmacy & Pharmaceutics.pptx
 
Fixed dose combination products – rationality, status in india, development i...
Fixed dose combination products – rationality, status in india, development i...Fixed dose combination products – rationality, status in india, development i...
Fixed dose combination products – rationality, status in india, development i...
 
The obnoxious practice of drug companies
The obnoxious practice of drug companiesThe obnoxious practice of drug companies
The obnoxious practice of drug companies
 
FDC Ban - What's Right and What's Wrong?
FDC Ban - What's Right and What's Wrong?FDC Ban - What's Right and What's Wrong?
FDC Ban - What's Right and What's Wrong?
 
Pharma Malpractices - Report of the Parliament Committee to Rajya Sabha
Pharma Malpractices - Report of the Parliament Committee to Rajya Sabha Pharma Malpractices - Report of the Parliament Committee to Rajya Sabha
Pharma Malpractices - Report of the Parliament Committee to Rajya Sabha
 
Regulatory Issues for ASU.ppt by Dr.U.Srinivasa
Regulatory Issues for ASU.ppt by Dr.U.SrinivasaRegulatory Issues for ASU.ppt by Dr.U.Srinivasa
Regulatory Issues for ASU.ppt by Dr.U.Srinivasa
 
Regulatory issues regulations in india asu
Regulatory issues   regulations in india asuRegulatory issues   regulations in india asu
Regulatory issues regulations in india asu
 
pharmacy act.pptx
pharmacy act.pptxpharmacy act.pptx
pharmacy act.pptx
 
History of pharmacy and pharmacopoeia
History of pharmacy and pharmacopoeiaHistory of pharmacy and pharmacopoeia
History of pharmacy and pharmacopoeia
 
India Ayurvedic.pdf Ayurveda Samhitha ayurvedic
India Ayurvedic.pdf Ayurveda Samhitha ayurvedicIndia Ayurvedic.pdf Ayurveda Samhitha ayurvedic
India Ayurvedic.pdf Ayurveda Samhitha ayurvedic
 
Sources of drug information
Sources of drug informationSources of drug information
Sources of drug information
 
Clinical pharmacy management
Clinical pharmacy management Clinical pharmacy management
Clinical pharmacy management
 
Pharmacy and Therapeutic committee
Pharmacy and Therapeutic committeePharmacy and Therapeutic committee
Pharmacy and Therapeutic committee
 
Pharmacy history, pharmacopoeia
Pharmacy history, pharmacopoeiaPharmacy history, pharmacopoeia
Pharmacy history, pharmacopoeia
 
Write a rational, correct and legible generic prescription for a given condit...
Write a rational, correct and legible generic prescription for a given condit...Write a rational, correct and legible generic prescription for a given condit...
Write a rational, correct and legible generic prescription for a given condit...
 
Medical jurisprudence
Medical jurisprudenceMedical jurisprudence
Medical jurisprudence
 
Pharmacy Act 1948
Pharmacy Act 1948Pharmacy Act 1948
Pharmacy Act 1948
 

More from Anup Soans

An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...
An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...
An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...Anup Soans
 
Key Challenges Facing Pharma Industry and the Way Forward
Key Challenges Facing Pharma Industry and the Way ForwardKey Challenges Facing Pharma Industry and the Way Forward
Key Challenges Facing Pharma Industry and the Way ForwardAnup Soans
 
Trends in Pharma Marketing - Focus and Spending
Trends in Pharma Marketing - Focus and SpendingTrends in Pharma Marketing - Focus and Spending
Trends in Pharma Marketing - Focus and SpendingAnup Soans
 
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27thMedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27thAnup Soans
 
Key Account Management - Time for India Pharma to Adopt KAM
Key Account Management - Time for India Pharma to Adopt KAMKey Account Management - Time for India Pharma to Adopt KAM
Key Account Management - Time for India Pharma to Adopt KAMAnup Soans
 
MedicinMan Report on Digital Readiness of Indian Pharma 2021
MedicinMan Report on Digital Readiness of Indian Pharma 2021MedicinMan Report on Digital Readiness of Indian Pharma 2021
MedicinMan Report on Digital Readiness of Indian Pharma 2021Anup Soans
 
How can Pharma Use Digital to Engage Doctors and Understand Patients
How can Pharma Use Digital to Engage Doctors and Understand PatientsHow can Pharma Use Digital to Engage Doctors and Understand Patients
How can Pharma Use Digital to Engage Doctors and Understand PatientsAnup Soans
 
Why Indian Pharma Needs to Enable Managers to Develop Talent
Why Indian Pharma Needs to Enable Managers to Develop TalentWhy Indian Pharma Needs to Enable Managers to Develop Talent
Why Indian Pharma Needs to Enable Managers to Develop TalentAnup Soans
 
Digital Excellence Pharma Academy Certification Program
Digital Excellence Pharma Academy Certification ProgramDigital Excellence Pharma Academy Certification Program
Digital Excellence Pharma Academy Certification ProgramAnup Soans
 
Digital Excellent Pharma Academy Certification Program
Digital Excellent Pharma Academy Certification ProgramDigital Excellent Pharma Academy Certification Program
Digital Excellent Pharma Academy Certification ProgramAnup Soans
 
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family Affairs
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family AffairsCOVID-19 Vaccine Roll Out Plan by Ministry of Health and Family Affairs
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family AffairsAnup Soans
 
Architecture To Develop Pharma Business Leaders For Today and Tomorrow
Architecture To Develop Pharma Business Leaders  For Today and Tomorrow  Architecture To Develop Pharma Business Leaders  For Today and Tomorrow
Architecture To Develop Pharma Business Leaders For Today and Tomorrow Anup Soans
 
What is Indian Pharma Thinking about Digital? A Research Project
What is Indian Pharma Thinking about Digital? A Research ProjectWhat is Indian Pharma Thinking about Digital? A Research Project
What is Indian Pharma Thinking about Digital? A Research ProjectAnup Soans
 
Digital Excellence Pharma Academy - Webinar & Online Certification Program
Digital Excellence Pharma Academy - Webinar & Online Certification ProgramDigital Excellence Pharma Academy - Webinar & Online Certification Program
Digital Excellence Pharma Academy - Webinar & Online Certification ProgramAnup Soans
 
Telemedicine Guidelines for Indian Doctors
Telemedicine Guidelines for Indian DoctorsTelemedicine Guidelines for Indian Doctors
Telemedicine Guidelines for Indian DoctorsAnup Soans
 
The Mankind Pharma Story by Dr. Sumit Ghoshal
The Mankind Pharma Story by Dr. Sumit GhoshalThe Mankind Pharma Story by Dr. Sumit Ghoshal
The Mankind Pharma Story by Dr. Sumit GhoshalAnup Soans
 
Indian Pharma and Retail Pharmacies - Sales View Poll
Indian Pharma and Retail Pharmacies - Sales View PollIndian Pharma and Retail Pharmacies - Sales View Poll
Indian Pharma and Retail Pharmacies - Sales View PollAnup Soans
 
Healthcare's Future will be Patient Experience
Healthcare's Future will be Patient ExperienceHealthcare's Future will be Patient Experience
Healthcare's Future will be Patient ExperienceAnup Soans
 
Unethical Practices in Pharma - Interesting Study from Pakistan
Unethical Practices in Pharma - Interesting Study from Pakistan Unethical Practices in Pharma - Interesting Study from Pakistan
Unethical Practices in Pharma - Interesting Study from Pakistan Anup Soans
 
MedicinMan December 2018 Issue
MedicinMan December 2018 IssueMedicinMan December 2018 Issue
MedicinMan December 2018 IssueAnup Soans
 

More from Anup Soans (20)

An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...
An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...
An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...
 
Key Challenges Facing Pharma Industry and the Way Forward
Key Challenges Facing Pharma Industry and the Way ForwardKey Challenges Facing Pharma Industry and the Way Forward
Key Challenges Facing Pharma Industry and the Way Forward
 
Trends in Pharma Marketing - Focus and Spending
Trends in Pharma Marketing - Focus and SpendingTrends in Pharma Marketing - Focus and Spending
Trends in Pharma Marketing - Focus and Spending
 
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27thMedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th
 
Key Account Management - Time for India Pharma to Adopt KAM
Key Account Management - Time for India Pharma to Adopt KAMKey Account Management - Time for India Pharma to Adopt KAM
Key Account Management - Time for India Pharma to Adopt KAM
 
MedicinMan Report on Digital Readiness of Indian Pharma 2021
MedicinMan Report on Digital Readiness of Indian Pharma 2021MedicinMan Report on Digital Readiness of Indian Pharma 2021
MedicinMan Report on Digital Readiness of Indian Pharma 2021
 
How can Pharma Use Digital to Engage Doctors and Understand Patients
How can Pharma Use Digital to Engage Doctors and Understand PatientsHow can Pharma Use Digital to Engage Doctors and Understand Patients
How can Pharma Use Digital to Engage Doctors and Understand Patients
 
Why Indian Pharma Needs to Enable Managers to Develop Talent
Why Indian Pharma Needs to Enable Managers to Develop TalentWhy Indian Pharma Needs to Enable Managers to Develop Talent
Why Indian Pharma Needs to Enable Managers to Develop Talent
 
Digital Excellence Pharma Academy Certification Program
Digital Excellence Pharma Academy Certification ProgramDigital Excellence Pharma Academy Certification Program
Digital Excellence Pharma Academy Certification Program
 
Digital Excellent Pharma Academy Certification Program
Digital Excellent Pharma Academy Certification ProgramDigital Excellent Pharma Academy Certification Program
Digital Excellent Pharma Academy Certification Program
 
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family Affairs
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family AffairsCOVID-19 Vaccine Roll Out Plan by Ministry of Health and Family Affairs
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family Affairs
 
Architecture To Develop Pharma Business Leaders For Today and Tomorrow
Architecture To Develop Pharma Business Leaders  For Today and Tomorrow  Architecture To Develop Pharma Business Leaders  For Today and Tomorrow
Architecture To Develop Pharma Business Leaders For Today and Tomorrow
 
What is Indian Pharma Thinking about Digital? A Research Project
What is Indian Pharma Thinking about Digital? A Research ProjectWhat is Indian Pharma Thinking about Digital? A Research Project
What is Indian Pharma Thinking about Digital? A Research Project
 
Digital Excellence Pharma Academy - Webinar & Online Certification Program
Digital Excellence Pharma Academy - Webinar & Online Certification ProgramDigital Excellence Pharma Academy - Webinar & Online Certification Program
Digital Excellence Pharma Academy - Webinar & Online Certification Program
 
Telemedicine Guidelines for Indian Doctors
Telemedicine Guidelines for Indian DoctorsTelemedicine Guidelines for Indian Doctors
Telemedicine Guidelines for Indian Doctors
 
The Mankind Pharma Story by Dr. Sumit Ghoshal
The Mankind Pharma Story by Dr. Sumit GhoshalThe Mankind Pharma Story by Dr. Sumit Ghoshal
The Mankind Pharma Story by Dr. Sumit Ghoshal
 
Indian Pharma and Retail Pharmacies - Sales View Poll
Indian Pharma and Retail Pharmacies - Sales View PollIndian Pharma and Retail Pharmacies - Sales View Poll
Indian Pharma and Retail Pharmacies - Sales View Poll
 
Healthcare's Future will be Patient Experience
Healthcare's Future will be Patient ExperienceHealthcare's Future will be Patient Experience
Healthcare's Future will be Patient Experience
 
Unethical Practices in Pharma - Interesting Study from Pakistan
Unethical Practices in Pharma - Interesting Study from Pakistan Unethical Practices in Pharma - Interesting Study from Pakistan
Unethical Practices in Pharma - Interesting Study from Pakistan
 
MedicinMan December 2018 Issue
MedicinMan December 2018 IssueMedicinMan December 2018 Issue
MedicinMan December 2018 Issue
 

Recently uploaded

PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medicationMohamadAlhes
 
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSapna Thakur
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfDivya Kanojiya
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Hypersensitivity and its classification .pptx
Hypersensitivity and its classification .pptxHypersensitivity and its classification .pptx
Hypersensitivity and its classification .pptxAkshay Shetty
 
Systemic Lupus Erythematosus -SLE PT2.ppt
Systemic  Lupus  Erythematosus -SLE PT2.pptSystemic  Lupus  Erythematosus -SLE PT2.ppt
Systemic Lupus Erythematosus -SLE PT2.pptraviapr7
 
SGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdf
SGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdfSGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdf
SGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdfHongBiThi1
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfHongBiThi1
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfDivya Kanojiya
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfDivya Kanojiya
 

Recently uploaded (20)

PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medication
 
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdf
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Hypersensitivity and its classification .pptx
Hypersensitivity and its classification .pptxHypersensitivity and its classification .pptx
Hypersensitivity and its classification .pptx
 
Systemic Lupus Erythematosus -SLE PT2.ppt
Systemic  Lupus  Erythematosus -SLE PT2.pptSystemic  Lupus  Erythematosus -SLE PT2.ppt
Systemic Lupus Erythematosus -SLE PT2.ppt
 
SGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdf
SGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdfSGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdf
SGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdf
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdf
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdf
 

IMA Letter on Prescribing Generics

  • 1. To The President MCI Dear Madam This is about the following circular being issued by the MCI. However, the clause 1.5 of the Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002 has been amended in 2016 and notified in the Gazette of India on 21.09.2016, which reads as under: "1.5 - Use of Generic names of drugs: Every physician should prescribe drugs with generic names legibly and preferably in capital letters and he/ she shall ensure that there is a rational prescription and use of drugs." IMA Observation: 1. Use of Generic names of drugs: Means the chemical name of the drug 2. Every physician: Means all doctors registered under IMR 3. ‘should” means discretional and non-mandatory 4. prescribe drugs with generic names: Means writing chemical name of the drug 5. Legibly: Means readable (does not mandate electronic writing) 6. and preferably (where ever possible and is non-mandatory) 7. in capital letters (pertains to the chemical name) 8. and he/ she shall ensure that there is a rational prescription and use of drugs means this part of the clause is mandatory (shall) B: All the Registered Medical Practitioners under the IMC Act are directed to comply with the aforesaid provisions of the Regulations without fail. IMA observation: To follow the above in its letter and spirit C: You are requested to give wide publicity of the above regulation to ensure that all the doctors practicing medicine under your jurisdiction comply with the regulation. IMA observation: IMA needs to disseminate this information.
  • 2. D: All concerned are once again urged to take necessary steps for observance of the aforesaid provision of the Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002 in its letter and spirit. IMA observation: same as B. E: For any doctor found violating clause l.5 of Ethics Regulation, suitable disciplinary action would be undertaken by the concerned SMC/MCI. IMA Observation: Only the mandatory portion of the clause can be actionable. The prescription shall have rationality of treatment and the drugs prescribed. The non-mandatory initial part of the clause can-not lead to action by SMCs as it is discretionary. F: “should prescribe drugs with generic names”: It does not write "only with generic names". It does not prohibit a doctor from writing the name of the company or the brand. For example when writing a generic name, we need to write the word ‘Jan Aushidhi’ in the prescription otherwise he or she will not get the cheapest quality drug etc. This classification may kindly be circulated to the SMCs to avoid any misunderstanding in its interpretation. Dr KK Aggarwal National President, IMA Background Note Generic drugs prescription Dr KK Aggarwal The current law situation is ““Every physician should prescribe drugs with generic names legibly and preferably in capital letters and he/she shall ensure that there is a rational prescription and use of drugs” 1. Every physician means all of us 2. ‘Should” means may and may means optional or preferable 3. Drugs with generic names means the chemical name of the drug 4. Legibly : means readable
  • 3. a. It does not mandate electronic prescription b. It does not mandate or it would have been shall and not should c. It does not include the word “only’ it only manes naming the chemical name of the drug In India. chemical generic name of the drug is available in three formats Generic generic Generic trade And generic brand All companies make all three versions. Generic brands are the costliest with no difference in quality IMA Stand 1. Choose drugs from national list of essential medicines (They are cheaper and of quality and efficacy) 2. When writing non NLEM take consent 3. When prescribing, write the cheapest available medicine and that will always be the generic- generic version of that company 4. Best will be to write the name of the salt and the name of the company you want to choose. No- body can stop you choosing the company for quality assurance. 5. When writing paracetamol from jan aushidhi you have to write the name jan aushidhi No. MCI-211(2)(Gen.)/2017-Ethics/104728 Date: 21/04/2017 To, 1. Dean/Principals of all the Medical Colleges, 2. Director of all the hospitals (exclusive PG Institutions without medical colleges), 3. President, all the State Medical Councils. 5. Health Secretary of all the States.; 5. The Director of Medical Education, all States with request to ensure compliance.6. The Director of Health Services, all States with request to ensure compliance and inform about action taken. Madam/Sir,
  • 4. Your kind attention is invited to circular no. MCI-211(2)(Gen.)/2012-Ethics/145183 dated 22.11.2012 & 18.01.2013. The said circular had called upon the doctors practicing medicine to prescribe Drugs with Generic name as far as possible. However, the clause 1.5 of the Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002 has been amended in 2016 and notified in the Gazette of India on 21.09.2016, which reads as under:- "1.5 - Use of Generic names of drugs: Every physician should prescribe drugs with generic names legibly and preferably in capital letters and he/ she shall ensure that there is a rational prescription and use of drugs." All the Registered Medical Practitioners under the IMC Act are directed to comply with the aforesaid provisions of the Regulations without fail. You are requested to give wide publicity of the above regulation to ensure that all the doctors practicing medicine under your jurisdiction comply with the regulation.“ All concerned are once again urged to take necessary steps for observance of the aforesaid provision of the Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002 in its letter and spirit. For any doctor found violating clausel.5 of Ethics Regulation, suitable disciplinary action would be undertaken by the concerned SMC/MCI. Secretary MCI IMA Comments Should is discretionary “ All the Registered Medical Practitioners under the IMC Act are directed to comply with the aforesaid provisions of the Regulations without fail” “For any doctor found violating clause l.5 of Ethics Regulation, suitable disciplinary action would be undertaken by the concerned SMC/MCI” We need to read the circular as a whole and not the first part only which is not mandated. The one which is mandated is (shall) is the second part of the clause and that is rational prescription. Only any irrational prescription can lead to an action.
  • 5. The first part of the clause contains the word ‘should” and not shall. Should is always discretionary. No. MCI-211(2)(Gen.)/2017-Ethics/104728 Date: 21/04/2017 To, 2. Dean/Principals of all the Medical Colleges, 2. Director of all the hospitals (exclusive PG Institutions without medical colleges), 3. President, all the State Medical Councils. 7. Health Secretary of all the States.; 5. The Director of Medical Education, all States with request to ensure compliance.6. The Director of Health Services, all States with request to ensure compliance and inform about action taken. 8. Madam/Sir, Your kind attention is invited to circular no. MCI-211(2)(Gen.)/2012-Ethics/145183 dated 22.11.2012 & 18.01.2013. The said circular had called upon the doctors practicing medicine to prescribe Drugs with Generic name as far as possible. However, the clause 1.5 of the Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002 has been amended in 2016 and notified in the Gazette of India on 21.09.2016, which reads as under:- "1.5 - Use of Generic names of drugs: Every physician should prescribe drugs with generic names legibly and preferably in capital letters and he/ she shall ensure that there is a rational prescription and use of drugs."
  • 6. All the Registered Medical Practitioners under the IMC Act are directed to comply with the aforesaid provisions of the Regulations without fail. You are requested to give wide publicity of the above regulation to ensure that all the doctors practicing medicine under your jurisdiction comply with the regulation.“ All concerned are once again urged to take necessary steps for observance of the aforesaid provision of the Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002 in its letter and spirit. For any doctor found violating clausel.5 of Ethics Regulation, suitable disciplinary action would be undertaken by the concerned SMC/MCI. Secretary MCI